NMTC
NASDAQNeuroOne Medical Technologies Corporation
SectorHealth CareIndustryMedical/Dental Instruments
Price$2.40-0.06 (-2.44%)
02:30 PM07:45 PM
News · 26 weeks37-40%
2026-01-182026-07-12
Mix1490d
- SEC Filings8(57%)
- Other4(29%)
- Insider2(14%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by NeuroOne Medical Technologies CorporationSCHEDULE 13G/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)
- INSIDERNew insider Pratt Brian claimed ownership of 1,085,934 shares (SEC Form 3)3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERMarket Development Director Christianson Mark sold $31,773 worth of shares (10,000 units at $3.18), decreasing direct ownership by 33% to 20,692 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECSEC Form 424B5 filed by NeuroOne Medical Technologies Corporation424B5 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECAmendment: SEC Form 10-Q/A filed by NeuroOne Medical Technologies Corporation10-Q/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form SD filed by NeuroOne Medical Technologies CorporationSD - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form SD filed by NeuroOne Medical Technologies CorporationSD - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Regulation FD Disclosure, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form 10-Q filed by NeuroOne Medical Technologies Corporation10-Q - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form SCHEDULE 13G filed by NeuroOne Medical Technologies CorporationSCHEDULE 13G - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Mills Jason Richard4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mathiesen Jeffrey S4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Buckman Paul4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Andrle Edward4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Christianson Mark4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mertens Steve4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Rosa David A4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
NMTC FAQ
6 questionsWhat does NeuroOne Medical Technologies Corporation do?
NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. NeuroOne Medical Technologies Corporation has a strategic partnership with RBC Medical Innovations to develop and manufacture a...Where does NMTC stock trade?
NeuroOne Medical Technologies Corporation (NMTC) is listed on NASDAQ.What sector and industry is NMTC in?
NeuroOne Medical Technologies Corporation operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about NMTC?
NeuroOne Medical Technologies Corporation has had 4 recent analyst actions on file. The most recent action was from Ladenburg Thalmann: Buy with a $145.00 price target on 2025-05-05. Recent price targets range from $145.00 to $600.00.What companies are similar to NMTC?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NMTC side-by-side with any of them on Quantisnow.How can I track NMTC on Quantisnow?
Quantisnow aggregates NeuroOne Medical Technologies Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NMTC to receive live email and push alerts on every new disclosure.